Have any questions?
+44 1234 567 890
ABOUT US
BOARD MEMBER
Frédéric Schynts
Frédéric Schynts is a scientist with virology, immunology and vaccinology background, experienced in vaccine, cell and gene therapy, and biologics development from R&D to clinical phase, business development and company development strategies. Furthermore, he is trained in the managerial and entrepreneurial aspects of the biotech Industry.
He worked for CROs and pharmaceutical companies (GSK, EyeD Pharma, CER Group) since 20+ years where he occupied various technical and senior managerial positions. Since 10+ years, he is an independent consultant, working for several biotech companies including companies developing cell and gene therapy. He joined the Belgian venture capital fund Noshaq as investment manager in 2020.